In contrast to traditional broad-spectrum antibiotics, it is difficult for bacteria to develop resistance to 20 most specifically targeted antimicrobial peptides (STAMPs), moreover, they can maintain a normal 21 ecological balance and provide long-term protection for the body. However, therapeutic applications of 22 STAMPS are hindered by their weak activity, and imperfect specificity as well as lack of knowledge to 23 understand their structure-activity relationships. To further investigate the effects of different parameters 24 on the biological activities of STAMPs, a peptide sequence, WKKIWK D PGIKKWIK, was truncated, 25 extended, and provided with an increased charge and altered amphipathicity. In addition, a novel 26 template modification method was introduced, in which a phage-displayed peptide that recognized and 27
Introduction 37
With the development of bacterial resistance, antibiotics to combat microbes are becoming limited. 38
Moreover, antibiotics are used to kill bacteria and result in the release of large amounts of 39 lipopolysaccharide (LPS), which is the major component of the outer membrane of Gram-negative 40 bacteria and induces serious complications, such as septic shock and severe sepsis [1] . For that reason, 41 there is a urge need for development of novel antimicrobial agents. Antimicrobial peptides (AMPs) are a 42 new class of antimicrobial agent that has the potential to substitute for traditional antibiotics. 43
Antimicrobial peptides (AMPs), which are part of the immune system, form the first line of defense 44 against pathogenic bacteria [2] . Compared with traditional antibiotics, AMPs possess a unique 45 mechanism, and it is widely accepted that the cytoplasmic membrane is the main target of AMPs [3] . 46
Because of this mechanism, bacteria have low potential to develop resistance to AMPs. However, AMPs 47 have similar activity profile to conventional antibiotics, showing broad-spectrum antimicrobial activities 48 against both Gram-negative and Gram-positive bacteria; these agents kill or inhibit benign and 49 pathogenic organisms indiscriminately, thus disrupting the homeostasis between a healthy microbiota 50 and the immune system [4, 5] . Consequently, there is an urgent need for novel antimicrobial peptides that 51 are capable of targeting specific pathogens without harming the normal flora. Specifically targeted 52 antimicrobial peptides (STAMPs) can maintain the ecological balance of normal microbial 53 communities [6] . Although researchers are now working on the development of targeted antibacterial 54 agents, some problems persist, such as the weak activity and poor specificity of STAMPs. At present, 55 the strategies used to improve the activity of broad-spectrum antimicrobial peptides are systematic 56 sequence extension or truncation, amino acid substitution, and increases in charge and 57 amphipathicity [7] , but how to improve the activity and specificity of STAMPs has been rarely reported to 58 date. 59 6 Results 86 Peptide characterization 87 The designed peptides were synthesized by Sangon Biotech (Shanghai, China) and purified to 88 greater than 95% purity using analytical reverse phase high-performance liquid chromatography 89 (RP-HPLC). The molecular weights of peptides were determined by matrix-assisted laser 90 desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF MS). The measured molecular 91 weights were close to the theoretical molecular weights, which indicated that the peptides were 92 successfully synthesized. 93
The following design methods were adopted to modify the parental peptide 2. 1) Change the length 94 of parental peptide 2. The ends of parental peptide 2 were truncated and extended, and each peptide 95 was simultaneously decreased or increased by two amino acids at both ends. Among them, peptide 1 96 was decreased by a total of 4 amino acids and peptides 3 and 4 were centered on the D PG Angle of 97 peptide 2 and sequentially extended at the N-and C-terminus in the order of KWIK and IKKW, 98 respectively. Peptides 3 and 4 were increased by a total of 4 and 8 amino acids, respectively. 2) 99
Increase charge of the parental peptide 2. To peptides 5 and 6 were added one and two lysines at the 100 end of the parental peptide, respectively. 3) Enhance the amphipathicity of parental peptide 2. As shown 101
in Figure 1A , peptides 7 and 8 were designed by substituting amino acids at the 2nd or 13th position of 102 parental peptide 2. Peptide 9 was designed by swapping the position of the 2nd and 13th amino acids of 103 parent peptide 2. In peptide 10, the β-turn unit was removed to become a perfect amphipathic peptide. 4) 104
Parental peptide 2, which connects the phage-displayed peptide at the N-or C-terminus, was used to 105 enhance the specific identification and binding ability of STAMP to E. coli. Phage-displayed peptide 14, 106 which was recruited from random peptide libraries, a whole-cell phage-display method was used to 107 isolate peptide 14 specifically binding to the cell surface of E. coli [15] . Moreover, during the construction 108 of the novel antimicrobial peptides with multi-domains, space hindrance often occurred because the 109 different domains of the peptides were too close to each other, thus inhibiting the biological functions of 110 7 shown in Figure 1 . 115
CD spectra 116
The secondary structures of the peptides were investigated by CD spectroscopy. SDS micelles 117 were used to simulate the anionic microbial membrane environment, and TFE was used to mimic the 118 hydrophobic environment [16] . As shown in Figure 2 , the spectra of most peptides were not 119 characteristic of the helix conformation in 10 mM PBS. By contrast, in 50% TFE, all peptides other than 120 14 tended to form an α-helical structure with two negative peaks at approximately 208 and 222 nm. In 121 the SDS environment, the [θ]220 values of peptide 1 (-728), 2 (-839), 3 (-1668) and 4 (-6924) showed 122 that when D PG was in the middle of the peptide sequence, the weaker helical structure of the peptide 123 was destroyed by D PG with the extension of the peptide sequence. Peptide 5 and 6 also showed helical 124
properties in SDS environments. The amphiphilicity of peptide 7, 8 and 9 was improved; however, the 125 helical propensity changes were not obvious. When D PG was removed, peptide 10 was converted into a 126 typical α-helical structure. Phage-displayed peptide 14 had a minimum at ≈ 200 nm and a value near 127 zero at 220 nm, supporting a disordered structure, and 11 and 12 exhibited two negative dichroic bands 128 at approximately 208 and 222 nm, indicating the predominance of α-helical structures, similar to the 129 results obtained for parental peptide 2. 130 8 beneficial bacteria, melittin possessed broad-spectrum antimicrobial activity, and no other peptides 145 except peptide 4 had any effect. Moreover, the ratio of GM (E. coli) to GM (other pathogenic strains) and 146 GM (E. coli) to GM (beneficial strains) was used to as the targeting index (TI); smaller targeting index 147 values indicated greater specific antimicrobial ability toward E. coli. Peptide 11 had the lowest TI all value 148 (0.028), which was 31 times lower than that of melittin (TI all =0.876). Compared with parental peptide 2 149 (TI all =0.067), the specificity of 11 for E. coli increased by 2.4 times; the specificities of 3 (TI all =0.040) and 150 12 (TI all =0.035) were also enhanced. 151
Hemolytic activity and cytotoxicity
152 Table 3 and Figure 3 summarize the peptide hemolytic activities. The results showed that 153 hemolysis of all peptides except 4 was less than 5% at all concentrations. Compared to melittin, all 154 peptides had significantly lower hemolytic activity (P<0.05). The ratio of MHC to GM served as the 155 selectivity index (SI), which indicated the cell selectivity of a peptide. Peptide 11 was found to have a 156 relatively high SI of 80.630, and although peptide 3 had a higher selectivity index than peptide 11, its TI 157 was only 0.040. In the cytotoxicity test of human embryonic kidney cells (HEK293T) and intestinal 158 porcine enterocyte cells (IPEC-J2) (Figure 4 ), the toxicity of extended peptide 4 and perfect amphipathic 159 peptide 10 was significant; peptide 4 killed approximately 99% of HEK293t and IPEC-J2 at 128 μM, 160 followed by peptide 10, which killed approximately 99% of HEK293t and 63% IPEC-J2. In contrast, 11 161 exhibited very high selectivity for two kinds of cells, and compared with 2, the toxicity was increased 162 minimally at 128 μM. 163
Salt, Serum, Acid and Alkali sensitivity 164
Peptides must maintain activity in a physiological environment for clinical applications. However, 165 many peptides have low stability in vivo and are susceptible to salt, serum, acid and alkaline conditions. 166
Thus, the antimicrobial activities of the peptides were tested following the addition of concentrations of 167 different salts, serum, acid and alkaline agents using a sensitivity assay ( Overall, 2 showed greater susceptibility compared with 11. 173
In the presence of NH 4 Cl, KCl, ZnCl 2 and FeCl 3 displayed relatively minimally repressive effects on 174 9 the anti-bacterial activities of the peptides. In serum, acid and alkaline sensitivity tests, the MIC values 175 of the peptides were not significantly increased. 176
LPS, LTA binding assays
177 Lipopolysaccharide (LPS) and lipoteichoic acid (LTA) are negative electrochemical components of 178
Gram-negative and Gram-positive bacteria, respectively, which can interact with positively charged 179
AMPs. As shown in Figure 5A and Figure 5B , the binding activity of 11 to LPS and LTA presented a 180 dose-dependent increase, the binding capacity of which was stronger than that of 2 and comparable to 181 that of melittin. Figure 5A and Figure 5B show a stronger fluorescence intensity for the binding activity of 182 11 with 50% E. coli at a low peptide concentration (2 μM) than that of melittin (21%) and parental 2 (6%), 183 and the binding capacity of 11 to E. coli LPS at 2 μM was stronger than that of P. aeruginosa LPS (16%) 184 and S. aureus LTA (23%). 185
Outer and inner membrane permeability 186
The potential of the peptides to permeabilize bacterial outer membranes was studied using 187 N-phenyl-1-naphthylamine (NPN) uptake assays [17] . The outer membrane is a unique component of 188
Gram-negative bacteria, which can provide an extra layer of protection to the organism. When the outer 189 membrane is damaged or disrupted, NPN binds to the phospholipid layer and provide fluorescence. As 190 shown in Figure 5C , a dose-dependent response of peptides in permeabilizing the outer membrane of 191
Gram-negative bacteria (E. coli and P. aeruginosa) was observed. In the presence of 2 μM peptide 11, 192 the permeability of the outer membrane was stronger than that of parental 2 and melittin, reaching 61% 193 and 27%, respectively, for E. coli and P. aeruginosa. 194
The inner membrane permeability was assessed by o-nitrophenol-β-D-galactoside (ONPG) assays, 195 which were used to detect the enterobacter in delayed lactose fermentation (containing Escherichia, 196 Klebsiella, etc.) [18] . When the inner membrane of E. coli is damaged, ONPG enters the cytoplasm, 197
where it can be hydrolyzed into galactose and yellow o-nitrophenol (ONP) by beta-galactosidase. 198
Therefore, inner membrane permeabilization can be measured by color changes in the culture medium. 199
As shown in Figure 5D , peptides 2 and 11 and melittin induced increases in the permeability of the inner 200 membrane from 0 to 4000 seconds at 2 μM. The optical density of 11 was significantly higher than that 201 of 2 and similar to that of melittin, indicating that the inner membrane permeability of 11 was obviously 202 stronger than that of parental 2. This phenomenon was largely consistent with the results of the outer 203 membrane permeability test. 204
Cytoplasmic membrane depolarization 205
The ability of 2, 11 and melittin to depolarize the membranes of intact E. coli, P. aeruginosa and S. 206 aureus cells was determined using the membrane potential-sensitive dye diSC 3 -5, which can become 207 concentrated in the cytoplasmic membrane based on the membrane potential, leading to the 208 self-quenching of fluorescence [19] . When the membrane potential is disrupted, the dye dissociates into 209 the buffer, causing an increase in fluorescence intensity. As shown in Figure 5E , in the cytoplasmic 210 membrane test of E. coli, the depolarization ability of 11 was enhanced compared with that of parental 2. 211
By contrast, 2 and 11 showed slight depolarization of the cytoplasmic membrane of P. aeruginosa 212 compared with melittin, potentially causing a small number of strains to rupture. For S. aureus, no 213 cytoplasmic membrane depolarization occurred within 800 seconds, suggesting that 2 and 11 were not 214 effective against membranes of S. aureus. We consider the above results to explain the 215 narrow-spectrum antibacterial activity of the peptides against E. coli. 216
SEM and TEM characterization 217
To further elucidate the narrow-spectrum antimicrobial mechanisms of 11, SEM and TEM were 218 implemented to study E. coli, P. aeruginosa and S. aureus morphological alterations, and parental 2 and 219 melittin were added for comparison. To evaluate the therapeutic effect of the peptides, we used the 220 same concentration of 2 μM. In the absence of peptide treatment, the bacterial cells had brilliant and 221 smooth membrane surfaces ( Figure 6 ). However, one hour after treatment with 11, membrane creping 222 and destruction were observed in E. coli cells; however, this phenomenon was not observed in most P. 223 aeruginosa and S. aureus and cells. In contrast to 11, parental 2 did not achieve an antibacterial effect 224 due to an insufficient concentration, and the E. coli cells were barely damaged. Melittin showed a 225 broad-spectrum antibacterial effect at this concentration, with significant membrane stunting and 226 corrugation on the surface of E. coli, P. aeruginosa and S. aureus. 227 TEM revealed the morphological and intracellular changes in E. coli, P. aeruginosa and S. aureus 228 cells after treatment with 2, 11 and melittin. Similarly, under TEM, after 60 min of treatment, 11 caused 229 substantial damage to E. coli membranes and outflow of the cytoplasm (Figure 7) . 230
Super-resolution microscopy (SRM) 231
The localization of FITC-labeled peptide 11 was studied by super-resolution microscopy. As shown 232
in Figure 8 , FITC-labeled peptide 11 was represented by green fluorescent signals on the surface and 233 inside of E. coli cells, while E. coli nucleic acid was stained with PI dye and observed as a red 234 11 fluorescent signal. The results distinctly indicated that 11 targeted the E. coli membrane surface and 235 compromised membrane integrity. 236
Flow cytometry 237
The DNA intercalating dye propidium iodide (PI) was used as an indicator to investigate E. coli, P. 238 aeruginosa and S. aureus cell death by flow cytometry (Figure 9 ). In the absence of peptide, the 239 percentage of E. coli 25922, P. aeruginosa 27853 and S. aureus 29213 cells with PI fluorescent signal 240 was 2.3%, 5.0%, and 5.2%, respectively. Treatment with 2 μM peptides showed that peptide 2 resulted 241 in 57.7% (E. coli), 31.3% (P. aeruginosa), and 14.9% (S. aureus) cell staining; peptide 11 resulted in 242 96.2% (E. coli), 33.0% (P. aeruginosa), and 11.0% (S. aureus) cell staining; and melittin resulted in the 243 staining of greater than 90% staining of all three bacteria. These results indicated that peptide 11 had 244 narrow-spectrum antibacterial activity against E. coli and induced more potent damage to E. coli than 245 the parental peptide. 246
Discussion

247
With the increase in antibiotic-resistant bacteria worldwide, the demand for novel antimicrobial 248 drugs to fight against infectious diseases is also increasing [20] . STAMPs represent a novel class of 249 therapeutic drugs that can be used to treat microbial infections without disrupting homeostasis. However, 250
there are many obstacles in the development of STAMPs that must be circumvented, including 251 optimization of STAMP specificity and activity. Template modification is performed using a naturally 252 occurring or designed AMP sequence as a starting template, followed by systematic sequence 253 extension or truncation, a charge increase, amino acid substitutions, and amphipathicity changes to 254 improve antimicrobial activities [7] . Previous researchers have commonly changed one or two key 255 parameters to transform peptides, resulting in few optimal sequences for therapeutic applications due to 256 weak activity; susceptibility to salt; serum, acid, and alkaline inactivation; and high cytotoxicity. In this 257 study, all the above factors were used in an attempt to improve the activity and specificity of STAMP, 258
and we focused on the effects of different design parameters on the antimicrobial spectrum and 259 biological activity of peptides. 260
The stable secondary structure of AMPs in the membrane environment is very important for their 261 biological activity [21] . Our results showed that most of the AMPs with disordered conformations in PBS 262 displayed a conversion to an α-helical conformation in TFE and SDS ( Figure 2 ). The helical propensity 263 of AMPs is typically affected by the composition of hydrophobic amino acids. Phage-displayed peptide 264 14 contained only three hydrophobic amino acids as well as proline, and proline residues can damage 265 the α-helical propensity. Thus, peptide 14 tended to form a disordered structure in membrane-like 266 environments. Similarly, D-Pro-Gly had a rigid bend that also disrupted the α-helical propensity; 267 therefore, except peptide 10, these peptides had a weak α-helical secondary structure signal in a 268 membrane-like environment. In comparison, peptide 10 and melittin had the typical α-helical 269
conformation. 270
As is known, the length of the sequence affects the activity of AMPs [22, 23] . We designed peptide 1 271 by removing two amino acids at both the N-and C-termini of parental peptide 2 without changing the 272 amino acid composition, which resulted in a loss of biological activity. This phenomenon suggested that 273
shortening the length of peptide 2 could not achieve the desired effect and that reducing four or more 274 reside(s) led to a gradual loss of biological activity. Moreover, peptide 1 had a reduced helical tendency 275 in SDS (Figure 2 ), suggesting that STAMPs require at least 14 amino acids to maintain helical a 276 13 structure able to span the membrane lipid bilayer. To further determine the optimal length of the peptide 277 for exerting narrow-spectrum antibacterial activity against E. coli, peptide 2 was extended, and the 278 designed peptides 3 and 4 showed increased activity against E. coli. Interestingly, peptide 4, which 279 contained 22 amino acids, exhibited broad-spectrum antibacterial activity, and the results showed that 280 STAMP could be converted into a broad-spectrum antimicrobial peptide after extending the sequences. 281
Although the activity of peptide 3 and 4 was enhanced in comparison to those of parental peptide 2, the 282 increase in sequence length also increased the toxicity of AMPs[24]. This phenomenon is consistent 283 with previous studies and might provide an explanation for the excess hydrophobicity of the longer 284 peptide molecule to obstruct the interaction between the peptide and zwitterionic phospholipids while 285 leading to a loss of cell selectivity [25, 26] . Therefore, in this study, we did not enhance the specificity 286 and activity of STAMPs by extending the sequence because this design approach conflicts with the low 287 cytotoxicity (Figures 3 and 4) . 288
The bacterial membrane contains anionic components, such as lipopolysaccharides, 289 mannoproteins, or anionic phospholipids, which can interact with AMP molecules via electrostatic 290
interactions [27] . AMPs aggregate on the membrane surface when they accumulate at a critical 291 concentration, followed by membrane lipid bilayer insertion, resulting in the destruction of the 292 membrane, leakage of the cytoplasm and cell death [28, 29] . Therefore, we speculate that increasing the 293 charge number of STAMPs can enhance the electrostatic interactions between the molecule and the 294 membrane to improve the antimicrobial activity and specificity. Arginine and lysine act as cationic 295 residues that can produce strong antibacterial activity under physiological conditions, while the use of 296 arginine residues is frequently associated with relatively higher hemolytic activities[30, 31]. To avoid 297 increased toxicity, we added one or two lysine residues to the C-terminus of parental peptide 2 and 298 designed peptides 5 and 6. Unfortunately, the activities of peptides 5 and 6 toward E. coli were not 299 enhanced compared with that of peptide 2 ( Table 2 and Table 3 ). Therefore, these findings indicate that 300 STAMPs are the same as broad-spectrum antimicrobial peptides, and the relationship between the 301 charge and biological activity is not linear, as increases of positive charges above a threshold (usually 302 5-6) did not result in increased antimicrobial activity [26, 32] . 303
Amphipathicity is another important parameter that can affect the antimicrobial activity of α-helical 304
AMPs [33] . The research of Khara, J. S showed that a perfect amphipathic of an α-helical AMP can 305 effectively enhance the antibacterial potential, but perfect amphipathicity often leads to a simultaneous 306 14 increase in activity and cytotoxicity [34] . Thus, a balance of amphipathicity is required to achieve the 307 satisfactory biological activity. In our search, peptides 7, 8, 9 and 10 contained amino acid replacements 308 to increase amphipathicity, but the results showed that the antibacterial activity of peptides 7, 8, and 9 309 against E. coli was weaker than that of parental peptide 2. In 30 mM SDS, the helical structures of 310 peptides 7, 8, and 9 were not significantly affected by the enhanced amphipathicity ( Figure 2) ; therefore, 311 the activity of the peptides was not improved. Simultaneously, perfect amphipathic peptide 10 showed 312 broad-spectrum antibacterial activity, as well as increased hemolysis and cytotoxicity. This result further 313 confirmed that perfect amphipathicity often results in increased hemolysis and cytotoxicity [35, 36] . 314
Moreover, this phenomenon showed that the antimicrobial activity and specificity of STAMPs could not 315 be enhanced by simply increasing the amphipathicity and that increasing amphipathicity may lead to a 316 transformation of STAMPs into broad-spectrum antimicrobial peptides. 317
Although the above structural parameters did not supply the STAMPs with ideal antibacterial activity, 318 a delicate balance among them may be required for the design of an ideal STAMP with increased 319 antibacterial activity and specificity. Therefore, hybrid peptides have become an attractive method to 320 optimize these sequences [37] . In this study, we used a phage-displayed peptide that was capable of 321 specific and strong binding to E. coli cells[15]. This peptide was attached to the N-or C-termini of 322 parental peptide 2 to give peptide 11 and 12 respectively. With the fusion of 14, 11 and 12 displayed 5.0 323 and 2.0 times increased antimicrobial activity relative to that of parental peptide 2 alone. A theory to 324 explain this phenomenon might be that 11 and 12 have a better hydrophobic and hydrophilic phase 325 balance than the parental peptide, resulting in enhanced antimicrobial activity because positive residues 326 and hydrophobic residues can bind to and insert into the cytoplasmic membranes [35] . Moreover, the 327 specific recognition ability of 11 and 12 to E. coli was enhanced by the addition of the phage-displayed 328 peptide. Hemolysis and cytotoxicity are important factors that limit the clinical application of 329 antimicrobial peptides; thus, it is important to evaluate the cytotoxic effect of peptides. Fortunately, our 330 target peptide 11 showed lower hemolysis and cytotoxicity (Figure 3 and Figure 4 ) at the level of the 331 average E. coli MIC value, demonstrating that the selectivity of 11 for the E. coli cell membrane 332 exceeded that for mammalian cell membrane [23] . 333
Previous reports have shown that the activity and cytotoxicity of peptides are often correlated with 334 their hydrophobicity and helical tendency [38, 39] . In membrane-like environments, 11 exhibited α-helical 335 characteristics and had weaker hydrophobicity and helical tendencies than melittin, potentially indicating 336 15 why target peptide 11 showed antimicrobial activity against E. coli and low cytotoxicity. This result 337 further confirmed that the activity and cytotoxicity were associated with the hydrophobicity and helical 338 tendencies. Therefore, when designing hybrid peptides using a phage-displayed peptide, the optimum 339 balance of hydrophobicity and helical tendency must be maintained. 340
Positively charged salt ions compete with peptide molecules to reduce the antibacterial activity of 341
AMPs [38] . In our research, Na + and Mg 2+ compromised the antimicrobial activity of peptides other than 342 4 against E. coli (Table 4) . At physiological concentrations, Na + and Mg 2+ reduce interactions between 343
AMPs and the membrane via the charge-shielding effect and thus reduce the antimicrobial activity 344 against E. coli. Moreover, Mg 2+ can bind LPS on the outer membrane of E. coli to prevent the proximity 345 of antibacterial peptide molecules [41, 42] . Therefore, increasing the charge can effectively replace the 346 salt ions around the membrane by an ion-exchange mechanism. Our results showed that the increased 347 charge of peptide 11 via terminal link phage-displayed peptide led to a reduction of salt ion sensitivity. 348
Furthermore, previous studies have confirmed that increases in hydrophobicity can also reduce the 349 adverse effects of salt ions on the antimicrobial activity of AMPs [43] . Peptide 4 maintained 350 broad-spectrum antimicrobial activity at a physiological salt concentration, which might be related to 351 both the overall hydrophobicity and the increased charge. Compared with our target peptide 11, peptide 352 4 showed the same amount of charge as peptide 11 (+10), but the overall hydrophobicity was stronger 353 than 11; therefore, peptide 4 showed improved salt stability. Moreover, all the designed peptides could 354 retain their original biological activities in serum, acid and alkaline environments. In conclusion, our 355 target peptide 11 maintained relatively satisfactory activity in a complex physiological environment 356 compared with its parental peptide 2. 357
Previous studies have proposed that broad-spectrum AMPs exert antimicrobial activity by 358 membrane permeabilization [44, 45] . However, the bactericidal mechanism of STAMPs is still unclear. 359 Therefore, we added the Gram-negative bacteria P. aeruginosa and Gram-positive bacteria S. aureus 360 as controls because previous MIC tests showed that peptide 11 did not have the ability to kill these two 361 strains ( Table 2) . LPS and LTA are the main components of Gram-negative bacteria and Gram-positive 362 bacteria, respectively, which can interact with AMPs via electrostatic interactions [44] . In our study, the 363 binding affinity of peptide 11 to LPS and LTA showed a dose-dependent effect ( Figure 5A and Figure 5B) , 364 which demonstrated that the interactions between STAMP 11 and LPS and LTA were only electrostatic 365 and that there was no specificity between strains, so peptide 11 could accumulate on the surface of the 366
Gram-negative and Gram-positive bacterial membrane. The outer membrane is a unique component of 367
Gram-negative bacteria, and AMP molecules must penetrate the outer membrane to get close to the 368 cytoplasmic membrane [47] . In general, the outer membrane of all Gram-negative bacteria possesses a 369 certain degree of permeability, allowing the exchange of small molecules and ions between the cell 370 interior and the extracellular medium [48, 49] . Peptide 11 could enhance the outer membrane 371 permeability of E. coli and P. aeruginosa in a dose-dependent manner ( Figure 5C ), but the penetration 372 of the outer membrane was not sufficient to kill the strains. When AMPs penetrate the outer membrane 373 and local peptides reach the threshold, AMP molecules can insert their hydrophobic cores into the 374 phospholipid bilayer of the cytoplasmic membrane, disrupting the membrane surface potential and 375 forming a mass of pore channels, finally resulting in cell lysis [50] . In cytoplasmic membrane 376 depolarization assays, we demonstrated that 11 could perturb the cytoplasmic membrane potential of E. 377 coli, had a slight effect on P. aeruginosa, but had no effect on S. aureus ( Figure 5E ). Therefore, we 378 believe selective destruction of the cytoplasmic membrane of E. coli by 11 supports a narrow-spectrum 379 antibacterial activity of the peptide against these cells ( Figure 10 ). The inner membrane permeability 380 results further indicated that 11 could induce cytoplasmic membrane leakage ( Figure 5D ). Direct 381 observation by SEM and TEM further confirmed the membrane damage effects of 11 on E. coli. The 382 super-resolution microscopy results showed that 11 damaged the cell membrane of E. coli. Furthermore, 383 flow cytometry analysis indicated that linkage of the displayed peptide at the end of the parental peptide 384 improved its anti-bacterial activity against E. coli. Altogether, 11 was observed to penetrate the outer 385 membrane of Gram-negative bacteria and destroy the cytoplasmic membrane potential to induce the 386 release of the cell contents, eventually leading to the death of E. coli. 387
Taken together, these findings provide a basic principle of peptide design and optimization to 388 enhance the activity and specificity of narrow-spectrum antimicrobial agents. In our study, we 389 successfully used a phage-displayed peptide to enhance the antimicrobial activity of STAMPs, while the 390 mechanism of direct action on bacterial membranes positions peptide 11 as a potential candidate 391 clinical treatment against E. coli. 392
393
Conclusion
394
In our study, we attempted to use the traditional approach to optimize a STAMP 2 with activity 395 against E. coli based on the principles of peptide chain length, amphipathicity, and charge number. A 396 series of peptides were synthesized and tested for their anti-bacterial properties, hemolytic activity, 397 cytotoxicity, and sensitivity. We found that STAMP is different from broad-spectrum antimicrobial 398 peptides, and it is difficult to achieve a satisfactory effect by changing only one parameter. In contrast, 399
we propose a feasible approach for the optimization of STAMP via the conjugation phage-displayed 400 peptide, which enhances STAMP antimicrobial potency and stability. In our system, 11 showed 401 enhanced narrow-antimicrobial activity against E. coli (TI all =0.028), while it had relatively high cell 402
selectivity. Peptide 11 accumulated on the surface of the membrane by binding LPS and LTA of negative 403 bacteria and positive bacteria, respectively, and permeabilized the outer membrane of Gram-negative 404 bacteria, but it only induced depolarization of the cytoplasmic membrane in E. coli, disrupting the inner 405 membrane integrity and eventually leading to target cell death. In summary, these results demonstrate a 406 potential method for the design or optimization of STAMPs. Simultaneously, peptide 11 has potential as 407 a novel agent against E. coli to help in preventing related diseases. 408 Where θ M is the residue ellipticity (deg×cm 2 ×dmol −1 ), θ obs is the measured ellipticity corrected for 440 the buffer at a given wavelength (mdeg), c is the peptide concentration (mM), l is the optical path length 441 (mm), and n is the number of amino acids. 442
Materials and Methods
Determination of the minimum inhibitory concentration (MIC)
443
Pathogenic strains cells were cultured in Mueller-Hinton Broth (MHB), whereas beneficial strains 444 were cultured in Lactobacilli MRS Broth (MRS). The MIC was determined in a 96-well plate. Briefly, 445 logarithmic phase cultures of pathogenic strains and beneficial strains were diluted in MHB and MRS to 446 a final concentration of 10 5 CFU/mL, the series of peptides were serially diluted in 0.2% BSA solution, 447 and the plate wells received aliquots of 50 μL each of the culture suspension followed by the addition of 448 50 μL of the diluted peptide; the final concentrations were 1, 2, 4, 8, 16, 32, 64, and 128 μM. Positive 449 controls containing cells alone were incorporated. After incubation for 24-25 hours at 37°C, the optical 450 density (OD) at 492 nm (Tecan, Austria) was measured, and the MIC was determined as the lowest 451 concentration of peptide that resulted in inhibition of 95% of the bacterial growth. A minimum of three 452 independent experiments (biological replicates) were conducted. 453
Hemolytic activity test 454
The hemolytic activity of the peptides was determined according to a previously described 455 method [49] . Fresh human red blood cells (hRBCs) were obtained from a healthy donor at the Hospital 456 of Northeast Agricultural University. The hRBCs were pelleted by centrifugation and washed three times 457 with PBS (1,000×g, 4°C, 5min). Then, the hRBCs were diluted 1:10 in 10 mM PBS (PH 7.4). Next, 50 458 μL of the hRBC solution and different concentrations of each peptide were mixed and incubated for 1 h 459 at 37°C. The 96-well plate was centrifuged, and the supernatant was transferred to a new plate. 460
Negative and positive controls for hemolytic activity were considered the hRBC suspension and hRBCs 461 lysed with 0.1% Triton X-100 in PBS, respectively. Hemoglobin release upon lysis of the hRBCs was 462 monitored at 570 nm using a microplate reader (TECAN GENios F129004; TECAN, Austria). The 463 peptide concentration causing 5% hemolysis was considered to be the minimal hemolytic concentration 464 (MHC). Hemolysis was calculated using the following equation: for 24 h at 37°C in 5% CO 2 . Cells without peptides served as controls. Next, the medium was replaced 472 with 50μL of an MTT solution (0.5 mg/mL) and incubated for 4 h at 37°C. Subsequently, the formazan 473 crystals were dissolved by the addition of 150 μL DMSO added to each well. The OD at 570 nm was 474 observed using a microplate reader (TECAN GENios F129004; TECAN, Austria). The results were from 475 three independent assays. 476
Salt, Serum, Acid and Alkaline sensitivity 477
Each salt powder at a physiological concentration (300 mM NaCl, 9 mM KCl, 2 mM MgCl 2 , 16 μM 478
ZnCl 2 , 12 μM NH 4 Cl, and 6 μM FeCl 3 ) was dissolved in BSA stock solutions of polymer, and the 479 subsequent steps were consistent with the MIC determination method. To evaluate the effect of serum, 480 acid and alkaline conditions on antimicrobial activity, the peptides were incubated at three different 481 serum levels (100%, 50%, 25%) and four different pH levels (pH=2, pH=4, pH=10, pH=12) for 4 h prior 482 to MIC determination. 483
LPS and LTA binding assay
484
LPS from E. coli O111:B4 and P. aeruginosa 10 and LTA from S. aureus were mixed with BC in 50 485 mL of Tris buffer (pH=7.4) and the solutions were incubated at room temperature for 4 h. Different 486 concentrations of peptide in 50 μL were added to a 96-well plate after serial dilution. Then, a 50 μL 487 aliquot of the LPS-probe mixture and LTA-probe mixture were added to each well. Subsequently, the 488 fluorescence was measured (excitation λ=580 nm, emission λ=620 nm) on a spectrofluorophotometer 489 precipitates were washed twice with 10 mM PBS and re-suspended to 0.2 OD at 600 nm. Then, 527 bacterial cells were incubated at 37°C up to 60 min with peptides at a concentration of 2 μM. 528
Subsequently, the samples were harvested (5000 g, 5 min) and fixed with 2.5% glutaraldehyde at 4°C 529 overnight. The cells were dehydrated for 10 min in each of a graded ethanol series (50, 70, 90, and 530 100%). The cells have then transferred to a mixture (v: v = 1: 1) of 100% ethanol and tertiary butanol 531 and absolute tertiary butanol for 15 min. Finally, the specimens were dehydrated in a critical point dryer 532 with liquid CO 2 , and the dehydrated specimens were coated with gold-palladium and observed using a 533
Hitachi S-4800 SEM (Hitachi, Japan). 534
TEM characterization 535
Pretreatment with the bacterial samples was conducted in the same way as for SEM treatment. 536
After treatment with a series of ethanol solutions (50, 70, 90, 100%) for 8 min, the samples have then 537 transferred to a mixture (v: v = 1: 1) of 100% ethanol and acetone and absolute acetone for 15 min. 538
Subsequently, the specimens were transferred to 1:1 mixture of absolute acetone and resin for 30 min 539 and then to absolute epoxy resin overnight. Finally, the specimens were stained with uranyl acetate and 540 lead citrate and observed using a Hitachi H-7650 TEM (Hitachi, Japan). 541
Super-resolution microscopy (SRM)
542
E. coli 25922 cells were incubated in the presence of FITC-labeled peptide 11 at 2 μM at 37°C for 543 60 min. The mixture was centrifuged (1000 g, 5 min) and washed two times with PBS buffer. Then, the 544 cells were resuspended and incubated with 10 μg/mL PI in PBS buffer for 15 min at 4 °C, and the 545 extracellular PI dye was removed by centrifugation. A smear was created, and images were captured 546 using a Deltavision OMX system with a 488 and 535 nm band pass filter for FITC and PI excitation, 547 respectively. 548 All data were subjected to one-way analysis of variance (ANOVA), and significant differences 555 between means were evaluated by the Tukey test for multiple comparisons. The data were analyzed 556 using the Statistical Package for the Social Sciences (SPSS) version 16.0 (Chicago, Illinois, USA). 557
Quantitative data are presented as the means ± standard deviation (SD). P < 0.05 was considered 558 statistically significant. 
